Hims & Hers Health Inc Ordinary Shares - Class A (HIMS)

Industry Drug Manufacturers - Specialty & Generic


This stock can be held in an Investment ISA and an Investment Account
Sell

$19.15

Buy

$19.24

arrow-down$-0.70 (-3.53%)

Prices updated at 03 Apr 2026, 00:59 EDT
| Prices minimum 15 mins delay
|
Prices in USD

Income statement

20242025
1,477m2,348m
1,173m1,733m
62m106m
4.194.50
126m128m
79m160m
Sales, General and administrative847m1,192m
Interest expenses--
Provision for income taxes-54m-4m
Operating expenses1,111m1,628m
Income before taxes72m124m
Net income available to common shareholders126m128m
0.580.57
Net interest income--
Advertising and promotion--
Net investment income, net--
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)0.530.51
Free cash flow per share0.65690.4711
Book value/share1.99262.5566
Debt equity ratio0.0198362.062653

Balance sheet

20242025
Current assets396m768m
Current liabilities221m404m
Total capital477m1,514m
Total debt11m1,121m
Total equity477m541m
Total non current liabilities--
Loans-973m
Total assets708m2,155m
Total liabilities--
Cash and cash equivalents221m229m
Common stock221m227m

Cash flow

20242025
Cash at beginning of period98m221m
Cash dividends paid--
198m57m
Investments (gains) losses-19m-1,025m
221m229m
Net income--
251m300m
-53m-243m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2026 Morningstar. All rights reserved.